Brain Cancer

The OncLive Brain Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of brain cancer, including glioma, glioblastoma multiforme, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in brain cancer.

Latest News

FDA Approves Dabrafenib Plus Trametinib for Pediatric Patients With BRAF V600E–Mutated Low-Grade Glioma

March 16th 2023

The FDA has approved dabrafenib with trametinib for the treatment of pediatric patients 1 year of age and older with low-grade glioma with a BRAF V600E mutation who require systemic therapy.

Susan Pandya, MD
Vorasidenib Meets PFS End Point in IDH1/2-Mutant Low-Grade Glioma

March 14th 2023

David A. Reardon, MD
Will Immunotherapy Become a Standard of Care for Glioblastoma?

March 10th 2023

The FDA has granted an orphan drug designation to Temferon for use as a potential therapeutic option in patients with glioblastoma multiforme.
Temferon Lands FDA Orphan Drug Status for Glioblastoma Multiforme

March 2nd 2023

FDA Grants Orphan Drug Designation to BEA-17 for Glioblastoma

February 1st 2023

Video Series
Video Interviews

More News